Pharmaceutical Executive July 15, 2024
The latest news for pharma industry insiders.
Merck Finalizes EyeBio Purchase
The acquisition in the ophthalmology space features a $1.3 billon cash payment, with the potential for an additional $1.7 billion if various milestones are met.
FDA Issues CRL for Once-Weekly Insulin for Type 1 Diabetes
FDA has issued a complete response letter for Novo Nordisk’s biologics license application for the once-weekly basal insulin icodec to treat patients with diabetes. The FDA is asking for information about the manufacturing process, as well as the type 1 diabetes indication.
Companies Sharply Criticize Draft U.S. Cyber Reporting Rules
Critical infrastructure operators say the proposed regulation is confusing and burdensome.
IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group
...Today's Sponsors
Today's Sponsor